Các triệu chứng đường tiểu dưới sau phẫu thuật cắt tuyến tiền liệt qua niệu đạo

Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474–9. Lee C, Kozlowski JM, Grayhack JT. Intrinsic and extrinsic factors controlling benign prostatic growth. Prostate. 1997;31:131–8. Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet. 2003;361:1359–67. American Urological Association - Management of Benign Prostatic Hyperplasia [Internet]. [cited 2018 Jun 7]. Available from: http://www.auanet.org/benign-prostatic-hyperplasia-(2010-reviewed-and-validity-confirmed-2014) Sarma AV, Wei JT. Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med. 2012;367:248–57. Zhao Y-R, Liu W-Z, Guralnick M, Niu W-J, Wang Y, Sun G, et al. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction. Int J Urol. 2014;21:1035–40. Nitti VW, Kim Y, Combs AJ. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings. J Urol. 1997;157:600–3. Bruskewitz RC, Larsen EH, Madsen PO, Dørflinger T. 3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol. 1986;136:613–5. Doll HA, Black NA, McPherson K, Flood AB, Williams GB, Smith JC. Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol. 1992;147:1566–73. Cho MC, Kim HS, Lee CJ, Ku JH, Kim SW, Paick J-S. Influence of detrusor overactivity on storage symptoms following potassium-titanyl-phosphate photoselective vaporization of the prostate. Urology. 2010;75:1460–6. Al-Rawashdah SF, Pastore AL, Salhi YA, Fuschi A, Petrozza V, Maurizi A, et al. Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes. World J Urol. 2017;35:1595–601. Skolarikos A, Rassweiler J, de la Rosette JJ, Alivizatos G, Scoffone C, Scarpa RM, et al. Safety and efficacy of bipolar versus monopolar transurethral resection of the prostate in patients with large prostates or severe lower urinary tract symptoms: post hoc analysis of a European multicenter randomized controlled trial. J Urol. 2016;195:677–84. Lukacs B, Loeffler J, Bruyère F, Blanchet P, Gelet A, Coloby P, et al. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol. 2012;61:1165–73. •• Thomas JA, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol. 2016;69:94–102. This randomized non-inferiority trial compared GreenLight laser vaporization of the prostate to standard TURP, and showed that at 24 months of follow-up, the long-term effectiveness and safety of the two modalities are similar. Mordasini L, Di Bona C, Klein J, Mattei A, Wirth GJ, Iselin CE. 80-W GreenLight laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic obstruction: 5-year outcomes of a single-center prospective randomized trial. Urology. 2018;116:144–9. Pereira-Correia JA, de Moraes Sousa KD, Santos JBP, de Morais PD, Lopes-da-Silva LF, Krambeck RL, et al. GreenLight HPS™120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int. 2012;110:1184–9. Bae J, Kang HW, Lee HW, Lee KS, Cho MC. Predictors of de novo urge urinary incontinence after photoselective vaporization of the prostate. World J Urol. 2016;34:413–8. Mirone V, Imbimbo C, Longo N, Fusco F. The detrusor muscle: an innocent victim of bladder outlet obstruction. Eur Urol. 2007;51:57–66. Ponholzer A, Temml C, Wehrberger C, Marszalek M, Madersbacher S. The association between vascular risk factors and lower urinary tract symptoms in both sexes. Eur Urol. 2006;50:581–6. Wada N, Watanabe M, Kita M, Matsumoto S, Kakizaki H. Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Neurourol Urodyn. 2012;31:659–63. Pinggera G-M, Mitterberger M, Pallwein L, Schuster A, Herwig R, Frauscher F, et al. Alpha-blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms. BJU Int. 2008;101:319–24. Lin Y-H, Hou C-P, Chen T-H, Juang H-H, Chang P-L, Yang P-S, et al. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan nationwide population-based cohort study. Clin Interv Aging. 2017;12:535–41. Barbosa JABA, Reis ST, Nunes M, Ferreira YA, Leite KR, Nahas WC, et al. The obstructed bladder: expression of collagen, matrix metalloproteinases, muscarinic receptors, and angiogenic and neurotrophic factors in patients with benign prostatic hyperplasia. Urology. 2017;106:167–72. Kohnen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol. 1979;121:755–60. Wu Y, Pan H, Wang W-M, Xu D, Zhang L, Gu Z-Q, et al. A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection. Asian J Androl. 2017;19:230–3. Litman HJ, Bhasin S, O’Leary MP, Link CL, McKinlay JB. BACH Survey Investigators. An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey. BJU Int. 2007;100:321–6. Huet R, Mathieu R, Rohou T, Peyronnet B, Manunta A, Verhoest G, et al. MRI assessment of tissue effects after 180-W XPS greenlight laser vaporization of the prostate. Lasers Surg Med. 2017;49:577–81. • Antunes AA, Iscaife A, Reis ST, Albertini A, Nunes MA, Lucon AM, et al. Can we predict which patients will experience resolution of detrusor overactivity after transurethral resection of the prostate? J Urol. 2015;193:2028–32. This study examined clinical and urodynamic variables as potential predictors for persistent LUTS at 12 months following TURP. Older age, lower cystometric capacity, and higher detrusor overactivity amplitude were predictive of persistent detrusor overactivity following TURP. Choi H, Kim JH, Shim JS, Park JY, Kang SH, Moon DG, et al. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement. Urol Int. 2014;93:425–30. Gormley EA, Griffiths DJ, McCracken PN, Harrison GM, McPhee MS. Effect of transurethral resection of the prostate on detrusor instability and urge incontinence in elderly males. Neurourol Urodyn. 1993;12:445–53. Seki N, Yuki K, Takei M, Yamaguchi A, Naito S. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction. Neurourol Urodyn. 2009;28:197–201. Kim MS, Park KK, Chung BH, Lee SH. Effect of photoselective vaporization prostatectomy on lower urinary tract symptoms in benign prostatic hyperplasia with or without intravesical prostatic protrusion. Korean J Urol. 2013;54:36–41. Guerios SD, Wang Z-Y, Boldon K, Bushman W, Bjorling DE. Blockade of NGF and trk receptors inhibits increased peripheral mechanical sensitivity accompanying cystitis in rats. Am J Phys Regul Integr Comp Phys. 2008;295:R111–22. Liu B, Zheng B, Zhou Z, Xu Z, Cai S. Change of nerve growth factor mRNA in human detrusor in bladder outlet obstruction with benign prostatic hyperplasia and their implication. Zhonghua Wai Ke Za Zhi. 2004;42:874–6. • Hu H, Zhang W, Liu X, Wang H, Fang Z, Liang C, et al. Nerve growth factor levels are associated with overactive bladder symptoms and long-term treatment outcome after transurethral resection of the prostate in patients with benign prostate hyperplasia. J Urol. 2018; This paper demonstrated that nerve growth factor levels can be used as a biomarker to predict the likelihood of having persistent LUTS following TURP. Fujita K, Kimura T, Saito K, Kitagawa M, Furuhata T, Uyama K, et al. Epididymitis after transurethral prostatectomy. Clin Ther. 1988;10 Spec No:56–9. Chughtai B, Simma-Chiang V, Kaplan SA. Evaluation and management of post-transurethral resection of the prostate lower urinary tract symptoms. Curr Urol Rep. 2014;15:434. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006;50:969–79. discussion 980 Kuo H-C. Analysis of the pathophysiology of lower urinary tract symptoms in patients after prostatectomy. Urol Int. 2002;68:99–104. Kahokehr A, Vather R, Nixon A, Hill AG. Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials. BJU Int. 2013;111:304–11. Kara C, Resorlu B, Cicekbilek I, Unsal A. Analgesic efficacy and safety of nonsteroidal anti-inflammatory drugs after transurethral resection of prostate. Int Braz J Urol. 2010;36:49–54. Chughtai B, Thomas D, Kaplan S. α-blockers, 5-α-reductase inhibitors, acetylcholine, β3 agonists, and phosphodiesterase-5s in medical management of lower urinary tract symptoms/benign prostatic hyperplasia: how much do the different formulations actually matter in the classes? Urol Clin N Am. 2016;43:351–6. Porru D, Campus G, Caria A, Madeddu G, Cucchi A, Rovereto B, et al. Impact of early pelvic floor rehabilitation after transurethral resection of the prostate. Neurourol Urodyn. 2001;20:53–9. Hou C-P, Chen T-Y, Chang C-C, Lin Y-H, Chang P-L, Chen C-L, et al. Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery. Clin Interv Aging. 2013;8:667–73.